Key Laboratory of Agricultural Environmental Microbiology, Ministry of Agriculture, College of Life Sciences, Nanjing Agricultural University, Nanjing 210095, PR China; College of Life Sciences, Shihezi University, Shihezi 832003, PR China.
State Key Laboratory of Materials-Oriented Chemical Engineering, College of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing 211800, China.
Int J Biol Macromol. 2023 Mar 31;232:123366. doi: 10.1016/j.ijbiomac.2023.123366. Epub 2023 Jan 21.
Polyhydroxyalkanoates (PHAs) as biodegradable plastics have attracted increasing attention due to its biodegradable, biocompatible and renewable advantages. Exploitation some unique microbes for PHAs production is one of the most competitive approaches to meet complex industrial demand, and further develop next-generation industrial biotechnology. In this study, a rare actinomycetes strain A7-Y was isolated and identified from soil as the first PHAs producer of Aquabacterium genus. Produced PHAs by strain A7-Y was identified as poly(3-hydroxybutyrate) (PHB) based on its structure characteristics, which is also similar with commercial PHB. After optimization of fermentation conditions, strain A7-Y can produce 10.2 g/L of PHB in 5 L fed-batch fermenter, corresponding with 54 % PHB content of dry cell weight, which is superior to the reported actinomycetes species. Furthermore, the phaCAB operon in stain A7-Y was excavated to be responsible for the efficient PHB production and verified in recombinant Escherichia coli. Our results indicate that strain A7-Y and its biosynthetic gene cluster are potential candidates for developing a microbial formulation for the PHB production.
聚羟基烷酸酯(PHAs)作为可生物降解塑料,由于其可生物降解、生物相容和可再生的优点,引起了越来越多的关注。利用一些独特的微生物生产 PHAs 是满足复杂工业需求和进一步发展下一代工业生物技术的最具竞争力的方法之一。在这项研究中,从土壤中分离出一株稀有放线菌 A7-Y,并将其鉴定为 Aquabacterium 属中的第一个 PHAs 生产菌。根据其结构特征,A7-Y 菌株产生的 PHAs 被鉴定为聚(3-羟基丁酸酯)(PHB),与商业 PHB 相似。在优化发酵条件后,A7-Y 菌株在 5L 分批补料发酵罐中可生产 10.2g/L 的 PHB,对应的细胞干重中 PHB 含量为 54%,优于已报道的放线菌属种。此外,还挖掘了 A7-Y 菌株中的 phaCAB 操纵子,该操纵子负责高效生产 PHB,并在重组大肠杆菌中得到了验证。我们的结果表明,A7-Y 菌株及其生物合成基因簇是开发 PHB 生产微生物制剂的潜在候选物。